Donnan Matthew, Siemienowicz Miranda, Tay Hui Sien, McLean Catriona, Philpot Steve, Mason Chris, Snell Greg, Glaspole Ian, Stirling Rob G
Department of Respiratory Medicine Alfred Health Melbourne Victoria Australia.
Department of Radiology Alfred Health Melbourne Victoria Australia.
Respirol Case Rep. 2024 Jul 15;12(7):e01434. doi: 10.1002/rcr2.1434. eCollection 2024 Jul.
Trimethoprim-sulfamethoxazole (TMP-SMX) acute respiratory distress syndrome (ARDS) is a rare, but severe complication of a commonly prescribed antibiotic. TMP-SMX typically affects young, otherwise well patients with a specific human leukocyte antigen type (HLA-B07:02 and HLA-C07:02). The condition is poorly understood with a unique pathological appearance and mechanism that remains unclear. Mortality rate is greater than one third. We describe the case of a previously well 18-year-old woman treated with a prolonged course of TMP-SMX for a complex urinary tract infection who developed rapidly progressive respiratory failure requiring prolonged intensive care admission, extra-corporeal membranous oxygenation, and eventual lung transplantation. No targeted treatment exists, further research is required to better understand disease pathogenetic mechanisms and potential therapeutic interventions.
甲氧苄啶-磺胺甲恶唑(TMP-SMX)所致急性呼吸窘迫综合征(ARDS)是一种常用抗生素引发的罕见但严重的并发症。TMP-SMX通常影响年轻且其他方面健康、具有特定人类白细胞抗原类型(HLA-B07:02和HLA-C07:02)的患者。人们对这种病症了解甚少,其独特的病理表现和机制仍不清楚。死亡率超过三分之一。我们描述了一例先前健康的18岁女性病例,她因复杂性尿路感染接受了长时间的TMP-SMX治疗,随后出现快速进展的呼吸衰竭,需要长时间入住重症监护病房、进行体外膜肺氧合,最终接受肺移植。目前尚无针对性治疗方法,需要进一步研究以更好地了解疾病发病机制和潜在的治疗干预措施。